[The vasoactive action of kurantil in patients with chronic glomerulonephritis]

Likars'Ka Sprava
|March 1, 1995
PubMed

Insights

Curantyl (C) treatment offers immediate benefits for chronic glomerulonephritis (ChGN) patients through its vasoactive and antiaggregant effects. Late results show sustained health improvements and slowed disease progression in a significant portion of patients.

Area of Science:

  • Nephrology
  • Pharmacology
  • Internal Medicine

Background:

  • Chronic glomerulonephritis (ChGN) is a progressive kidney disease.
  • Effective treatment strategies for ChGN are crucial for managing patient outcomes.
  • Curantyl (C) is a medication with known vasoactive and antiaggregant properties.

Purpose of the Study:

  • To evaluate the immediate and late therapeutic effects of Curantyl (C) in patients with chronic glomerulonephritis (ChGN).
  • To identify patient subgroups that benefit most from Curantyl (C) treatment.
  • To assess the long-term impact of Curantyl (C) on ChGN progression.

Main Methods:

  • A 3-4 week course of Curantyl (C) treatment was administered to ChGN patients.
  • Immediate treatment outcomes were assessed.
  • Late results were analyzed 1.5-2 years after Curantyl (C) withdrawal.
  • Comparison with a control group was performed.

Main Results:

  • Immediate positive effects of Curantyl (C) were attributed to its vasoactive and antiaggregant actions.
  • A negative immediate outcome, "steal syndrome," was observed in some patients.
  • Curantyl (C) was effective in ChGN patients with predominant fibroplastic changes, hypertension (grade I), and early-stage disease.
  • Late analysis revealed health status improvement in 22.5% and slowed ChGN progression in 15% of patients compared to controls.

Conclusions:

  • Curantyl (C) demonstrates both short-term benefits and potential long-term advantages in managing chronic glomerulonephritis (ChGN).
  • Careful patient selection is advised due to potential side effects like "steal syndrome."
  • Further research may explore optimizing Curantyl (C) use for sustained ChGN management.

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...